| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ANKRD12_0007200 | Exon-Exon | chr18:9195622-9204542 | chr18:9195624-9204544 | 144 nt | 0.3819 |
| hsa_ANKRD12_0008100 | Exon-Exon | chr18:9204474-9211782 | chr18:9204476-9211784 | 417 nt | 0.3909 |
| hsa_ANKRD12_0008200 | Exon-Exon | chr18:9204474-9221997 | chr18:9204476-9221999 | 708 nt | 0.4054 |
| hsa_ANKRD12_0009100 | Intron-Exon-Intron | chr18:9204474-9235907 | chr18:9204476-9235909 | 980 nt | 0.3918 |
| hsa_ANKRD12_0008300 | Intron-Exon-Intron | chr18:9204474-9239554 | chr18:9204476-9239556 | 250 nt | 0.2880 |
| hsa_ANKRD12_0008400 | Exon-Exon | chr18:9204474-9275665 | chr18:9204476-9275667 | 250 nt | 0.3240 |
| hsa_ANKRD12_0009600 | Intron-Exon-Intron | chr18:9204706-9221997 | chr18:9204708-9221999 | 250 nt | 0.3480 |
| hsa_ANKRD12_0009900 | Exon-Exon | chr18:9208655-9208801 | chr18:9208657-9208803 | 147 nt | 0.4082 |
| hsa_ANKRD12_0010300 | Exon-Exon | chr18:9208655-9221997 | chr18:9208657-9221999 | 639 nt | 0.4053 |
| hsa_ANKRD12_0010400 | Intron-Exon-Intron | chr18:9208655-9239554 | chr18:9208657-9239556 | 250 nt | 0.2840 |
A study in humans demonstrated that circANKRD12 circANKRD12 was significantly upregulated in the peripheral blood of myocardial infarction patients compared to healthy controls, with RT-qPCR validation showing high diagnostic efficacy as reflected by an area under the curve of 0.7819 in receiver operating characteristic analysis [Li et al. DOI:10.3389/fcvm.2022.810257]. A study in humans demonstrated that the circANKRD12 was identified as a differentially expressed circular RNA in the peripheral blood of myocardial infarction patients and was confirmed in an AC16 cell model [Tian et al. DOI: 10.3390/molecules26041155].